These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18436567)

  • 1. Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo.
    Wang YD; Yang F; Chen WD; Huang X; Lai L; Forman BM; Huang W
    Mol Endocrinol; 2008 Jul; 22(7):1622-32. PubMed ID: 18436567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
    Song KH; Li T; Owsley E; Strom S; Chiang JY
    Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.
    Wang YD; Chen WD; Li C; Guo C; Li Y; Qi H; Shen H; Kong J; Long X; Yuan F; Wang X; Huang W
    Mol Endocrinol; 2015 Feb; 29(2):322-31. PubMed ID: 25496033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
    Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
    Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
    J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
    Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesoid X receptor represses hepatic lipase gene expression.
    Sirvent A; Verhoeven AJ; Jansen H; Kosykh V; Darteil RJ; Hum DW; Fruchart JC; Staels B
    J Lipid Res; 2004 Nov; 45(11):2110-5. PubMed ID: 15342685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
    Haga S; Yimin ; Ozaki M
    BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
    Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
    J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.
    Peng Z; Raufman JP; Xie G
    PLoS One; 2012; 7(10):e48461. PubMed ID: 23119029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver.
    Wang B; Zhang H; Luan Z; Xu H; Wei Y; Zhao X; Xing M; Huo X; Zhang J; Su W; Guan Y; Zhang X
    Exp Cell Res; 2020 May; 390(1):111949. PubMed ID: 32145254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells.
    Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F
    J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid-induced tissue factor activity in hepatocytes correlates with activation of farnesoid X receptor.
    Greimel T; Jahnel J; Pohl S; Strini T; Tischitz M; Meier-Allard N; Holasek S; Meinel K; Aguiriano-Moser V; Zobel J; Haidl H; Gallistl S; Panzitt K; Wagner M; Schlagenhauf A
    Lab Invest; 2021 Oct; 101(10):1394-1402. PubMed ID: 34145381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
    Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
    J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GW4064 attenuates lipopolysaccharide‑induced hepatic inflammation and apoptosis through inhibition of the Toll‑like receptor 4‑mediated p38 mitogen‑activated protein kinase signaling pathway in mice.
    Liu HM; Lee TY; Liao JF
    Int J Mol Med; 2018 Mar; 41(3):1455-1462. PubMed ID: 29328388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.